p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients (Q74067210)
Jump to navigation
Jump to search
scientific article published on 01 July 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients |
scientific article published on 01 July 2000 |
Statements
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients (English)
Bottini A
Berruti A
Bersiga A
Brizzi MP
Brunelli A
Gorzegno G
DiMarco B
Aguggini S
Bolsi G
Cirillo F
Filippini L
Betri E
Bertoli G
Alquati P